Dr. Grothey on the Potential Utility of TAS-102/Bevacizumab in Metastatic CRC

The Impact of Minimal Residual Disease in Cancer

How Dr. Matthew Ballo helped transform West into a holistic cancer center

Advances in Cancer Immunotherapy Program, Saturday, March 20

West Cancer Center & Research Institute with record attendance at their 6th Annual West Oncology Conference